About Jorge Luis Rivera Agosto

This author has not yet filled in any details.
So far Jorge Luis Rivera Agosto has created 12 blog entries.

For the Living, a Donated Face. For the Dead, a Lifelike Replacement.

NYU surgeons hope a 3-D printed reproduction will encourage people to donate the faces of dying family members for use as transplants. By ANDY NEWMAN and MARC SANTORA JAN. 5, 2018 Most medical advances benefit the living. This one is for the dead. Sometime in the coming weeks or months, a brain-dead person, probably a man, will be wheeled [...]

By | January 9th, 2018|News-Articles|2 Comments

December 2016 Newsletter


By | December 20th, 2016|News-Letters|0 Comments

GBI excited to ​announce new President, Dr. Bruce Gelb

Global Bioethics Initiative is pleased to announce the election of Dr. Bruce Gelb, M.D., F.A.C.S, as President of the Board of Directors. Dr. Gelb is an Assistant Professor of Surgery at NYU Langone Medical Center, School of Medicine, and the Surgical Director of Renal Transplantation of the NYU Langone Transplant Institute. He also performs liver [...]

By | December 13th, 2016|News-Articles|0 Comments

​​​The future of ​b​ioethics under President-elect Trump: Professor ​​Moreno​’s Thoughts​

It is difficult to predict the fate of bioethics in the coming years under the new President-elect Trump, states Professor Jonathan Moreno, an Advisory Board member of Global Bioethics Initiative.  He is also a Professor of Medical Ethics and Health Policy, History and Sociology of Science, and of Philosophy. In 2008-09 he served as a member [...]

By | November 16th, 2016|News-Articles|0 Comments

After the election bioethics faces a rocky road

By Arthur Caplan Academic bioethics has never been popular with Republicans. Libertarians dislike academic bioethics because it seems too elitist and anti-free market.  Religious thinkers worry it is technocratic, soulless and crassly utilitarian. Now with Trumpism add a populist disdain for expertise, experts and the scientific method and you have a stew that means few [...]

By | November 11th, 2016|News-Articles|0 Comments

Novel system to get dying patients an experimental cancer drug raises hopes — and thorny questions

By KAREN WEINTRAUB @kweintraub NOVEMBER 8, 2016 The drug was still experimental, but clinical trials suggested it could be a lifesaver for patients with a lethal form of blood cancer called multiple myeloma. And those patients were clamoring to get it. They overwhelmed drug maker Janssen Pharmaceuticals with requests for the medication. Most companies [...]

By | November 11th, 2016|News-Articles|0 Comments

The most extensive face transplant performed by surgeons at NYU Langone Medical Center

Face transplants are slowly becoming an everyday surgery in the world. Just this past August, Dr. Eduardo Rodríguez performed one. In a 26-hour operation, the most extensive face transplant operation to date, the plastic surgeon and his team removed the face and scalp of a young victim of a fatal accident and successfully grafted the [...]

By | November 5th, 2016|News-Articles|0 Comments

Successful Launch Dubrovnik Summer School Program, August 5 – 14, 2016

  Global Bioethics Initiative in partnership with the University of Zagreb School of Medicine and Inter-University Centre invited students and professionals worldwide to attend Dubrovnik International Bioethics Summer School, August 5-14, 2016 - DIBSS. Our summer school program brought together brilliant minds from around the world and we welcomed them on August 5th, to the first International Bioethics Summer [...]

By | October 9th, 2016|News-Articles|0 Comments

One Step Closer to Tailored-Made Humans

The researcher and biologist Fredrik Lanner, from the Karolinska Institute in Stockholm, started to edit the DNA of healthy human embryos. This is the first reported action taken in gene editing on developing human embryos in the world; it’s another step onward to ultimately tailor-make a human being. Such procedure is still banned in most [...]

By | October 7th, 2016|News-Articles|0 Comments

Drug Prices: What Can Be Done?

In it's latest opinion, Dr. Elisabeth Rosenthal, argues that everyday drugs like EpiPen, should be economically affordable to all. After Mylan, the pharmaceutical company and owner of EpiPen, raised the drug's price from $100 in 2008 to $600 this year, it received a series of critics and backlash. This resulted in Mylan offering patients co-payments on the [...]

By | September 3rd, 2016|News-Articles|0 Comments